ID   VHB-1
AC   CVCL_M381
DR   Wikidata; Q54993154
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=2824520;
CC   Doubling time: 37 hours (Note=At 25th passage), 31 hours (Note=At 87th passage) (PubMed=2824520).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
RX   PubMed=2824520; DOI=10.1007/BF00390864;
RA   Vandewalle, Berre
RA   Collyn-d'Hooghe, Maude
RA   Savary, Jean-Bernard
RA   Vilain, Marie-Odile
RA   Peyrat, Jean-Philippe
RA   Deminatti, Marc-Marie
RA   Delobelle-Deroide, Alice
RA   Lefebvre, Jacqueline
RT   "Establishment and characterization of a new cell line (VHB-1) derived
RT   from a primary breast carcinoma.";
RL   J. Cancer Res. Clin. Oncol. 113:550-558(1987).
//
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RA   Leibovitz, Albert
RT   "Cell lines from human breast.";
RL   (In book chapter) Atlas of human tumor cell lines; Hay, Robert J. & Park, Jae-Gahb & Gazdar, Adi F. (eds.); pp.161-184; Academic Press; New York; USA (1994).
//